Anti-DYRK4 antibody - Carboxyterminal end (ab37911)

Overview

  • Product nameAnti-DYRK4 antibody - Carboxyterminal end
    See all DYRK4 primary antibodies
  • Description
    Rabbit polyclonal to DYRK4 - Carboxyterminal end
  • Tested applicationsSuitable for: ELISA, WBmore details
  • Species reactivity
    Reacts with: Human
  • Immunogen

    Synthetic peptide corresponding to Human DYRK4 aa 455-485 (C terminal) conjugated to Keyhole Limpet Haemocyanin (KLH).

Properties

Applications

Our Abpromise guarantee covers the use of ab37911 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
ELISA 1/1000.
WB 1/100 - 1/500. Predicted molecular weight: 60 kDa.

Target

  • FunctionPossible non-essential role in spermiogenesis.
  • Sequence similaritiesBelongs to the protein kinase superfamily. CMGC Ser/Thr protein kinase family. MNB/DYRK subfamily.
    Contains 1 protein kinase domain.
  • Post-translational
    modifications
    Autophosphorylated on tyrosine residues.
  • Cellular localizationCytoplasm.
  • Information by UniProt
  • Database links
  • Alternative names
    • Dual specificity tyrosine phosphorylation regulated kinase 4 antibody
    • Dual specificity tyrosine-phosphorylation-regulated kinase 4 antibody
    • Dyrk4 antibody
    • DYRK4_HUMAN antibody
    • EC 2.7.12.1 antibody
    see all

Anti-DYRK4 antibody - Carboxyterminal end images

  • Anti-DYRK4 antibody - Carboxyterminal end (ab37911) + Jurkat cell lysate

    Predicted band size : 60 kDa
    Observed band size : 60 kDa

References for Anti-DYRK4 antibody - Carboxyterminal end (ab37911)

ab37911 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab37911.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"